Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDK2 Antikörper

CDK2 Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN965843
  • Target Alle CDK2 Antikörper anzeigen
    CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
    Reaktivität
    • 183
    • 100
    • 79
    • 10
    • 10
    • 8
    • 8
    • 8
    • 6
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    Human, Maus, Ratte
    Wirt
    • 185
    • 23
    • 1
    Kaninchen
    Klonalität
    • 172
    • 37
    Polyklonal
    Konjugat
    • 103
    • 19
    • 15
    • 10
    • 7
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    Dieser CDK2 Antikörper ist unkonjugiert
    Applikation
    • 176
    • 77
    • 52
    • 52
    • 49
    • 39
    • 34
    • 28
    • 20
    • 13
    • 10
    • 8
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC)
    Spezifität
    CDK2 (Ab-160) antibody detects endogenous levels of total CDK2 protein.
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogen
    The antiserum was produced against synthesized non-phosphopeptide derived from human CDK2 around the phosphorylation site of threonine160 (T-Y-TP-H-E).
    Top Product
    Discover our top product CDK2 Primärantikörper
  • Applikationshinweise
    WB: 1:500~1:1000.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    100ug/100ul.
    Buffer
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
  • Liu, Wu, Galaktionov: "p42, a novel cyclin-dependent kinase-activating kinase in mammalian cells." in: The Journal of biological chemistry, Vol. 279, Issue 6, pp. 4507-14, (2004) (PubMed).

    Ukomadu, Dutta: "Inhibition of cdk2 activating phosphorylation by mevastatin." in: The Journal of biological chemistry, Vol. 278, Issue 7, pp. 4840-6, (2003) (PubMed).

    Morris, Gondeau, Tainer, Divita: "Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk." in: The Journal of biological chemistry, Vol. 277, Issue 26, pp. 23847-53, (2002) (PubMed).

    Brown, Noble, Lawrie, Morris, Tunnah, Divita, Johnson, Endicott: "Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity." in: The Journal of biological chemistry, Vol. 274, Issue 13, pp. 8746-56, (1999) (PubMed).

  • Target
    CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
    Andere Bezeichnung
    CDK2 (CDK2 Produkte)
    Synonyme
    p33(CDK2) antikoerper, A630093N05Rik antikoerper, wu:fa10c02 antikoerper, zgc:56598 antikoerper, zgc:77684 antikoerper, eg1 antikoerper, CDKN2 antikoerper, cdk2L antikoerper, cyclin dependent kinase 2 antikoerper, cyclin-dependent kinase 2 antikoerper, cyclin-dependent kinase 2 S homeolog antikoerper, CDK2 antikoerper, Cdk2 antikoerper, cdk2 antikoerper, cdk2.S antikoerper
    Pathways
    PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Synthesis of DNA
Sie sind hier:
Kundenservice